Highlights
The global Microneedles and Needle-Free Injection Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Microneedles and Needle-Free Injection Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Microneedles and Needle-Free Injection Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Microneedles and Needle-Free Injection Systems in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Microneedles and Needle-Free Injection Systems include Inovio Pharmaceuticals, 3M, Medical International Technology, D'Antonio Consultants International, Enesi Pharma, PharmaJet, Inolife Sciences, Valeritas and NanoPass Technologies, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microneedles and Needle-Free Injection Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles and Needle-Free Injection Systems.
The Microneedles and Needle-Free Injection Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Microneedles and Needle-Free Injection Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedles and Needle-Free Injection Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Inovio Pharmaceuticals
3M
Medical International Technology
D'Antonio Consultants International
Enesi Pharma
PharmaJet
Inolife Sciences
Valeritas
NanoPass Technologies
Micropoint Technologies
Nemaura Pharma
Segment by Type
Disposable Use
Re-usable Use
Segment by Application
Infectious Disease
Osteoarthritis
Painful Disease
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microneedles and Needle-Free Injection Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Disposable Use
1.2.3 Re-usable Use
1.3 麻豆原创 by Application
1.3.1 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Disease
1.3.3 Osteoarthritis
1.3.4 Painful Disease
1.3.5 Cancer
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Perspective (2018-2029)
2.2 Microneedles and Needle-Free Injection Systems Growth Trends by Region
2.2.1 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Microneedles and Needle-Free Injection Systems Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Microneedles and Needle-Free Injection Systems Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Microneedles and Needle-Free Injection Systems 麻豆原创 Dynamics
2.3.1 Microneedles and Needle-Free Injection Systems Industry Trends
2.3.2 Microneedles and Needle-Free Injection Systems 麻豆原创 Drivers
2.3.3 Microneedles and Needle-Free Injection Systems 麻豆原创 Challenges
2.3.4 Microneedles and Needle-Free Injection Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microneedles and Needle-Free Injection Systems Players by Revenue
3.1.1 Global Top Microneedles and Needle-Free Injection Systems Players by Revenue (2018-2023)
3.1.2 Global Microneedles and Needle-Free Injection Systems Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microneedles and Needle-Free Injection Systems Revenue
3.4 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Concentration Ratio
3.4.1 Global Microneedles and Needle-Free Injection Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microneedles and Needle-Free Injection Systems Revenue in 2022
3.5 Microneedles and Needle-Free Injection Systems Key Players Head office and Area Served
3.6 Key Players Microneedles and Needle-Free Injection Systems Product Solution and Service
3.7 Date of Enter into Microneedles and Needle-Free Injection Systems 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Microneedles and Needle-Free Injection Systems Breakdown Data by Type
4.1 Global Microneedles and Needle-Free Injection Systems Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Microneedles and Needle-Free Injection Systems Forecasted 麻豆原创 Size by Type (2024-2029)
5 Microneedles and Needle-Free Injection Systems Breakdown Data by Application
5.1 Global Microneedles and Needle-Free Injection Systems Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Microneedles and Needle-Free Injection Systems Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Microneedles and Needle-Free Injection Systems 麻豆原创 Size (2018-2029)
6.2 North America Microneedles and Needle-Free Injection Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2018-2023)
6.4 North America Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microneedles and Needle-Free Injection Systems 麻豆原创 Size (2018-2029)
7.2 Europe Microneedles and Needle-Free Injection Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2018-2023)
7.4 Europe Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microneedles and Needle-Free Injection Systems 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Microneedles and Needle-Free Injection Systems 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microneedles and Needle-Free Injection Systems 麻豆原创 Size (2018-2029)
9.2 Latin America Microneedles and Needle-Free Injection Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microneedles and Needle-Free Injection Systems 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Microneedles and Needle-Free Injection Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Microneedles and Needle-Free Injection Systems 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Inovio Pharmaceuticals
11.1.1 Inovio Pharmaceuticals Company Detail
11.1.2 Inovio Pharmaceuticals Business Overview
11.1.3 Inovio Pharmaceuticals Microneedles and Needle-Free Injection Systems Introduction
11.1.4 Inovio Pharmaceuticals Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.1.5 Inovio Pharmaceuticals Recent Development
11.2 3M
11.2.1 3M Company Detail
11.2.2 3M Business Overview
11.2.3 3M Microneedles and Needle-Free Injection Systems Introduction
11.2.4 3M Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.2.5 3M Recent Development
11.3 Medical International Technology
11.3.1 Medical International Technology Company Detail
11.3.2 Medical International Technology Business Overview
11.3.3 Medical International Technology Microneedles and Needle-Free Injection Systems Introduction
11.3.4 Medical International Technology Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.3.5 Medical International Technology Recent Development
11.4 D'Antonio Consultants International
11.4.1 D'Antonio Consultants International Company Detail
11.4.2 D'Antonio Consultants International Business Overview
11.4.3 D'Antonio Consultants International Microneedles and Needle-Free Injection Systems Introduction
11.4.4 D'Antonio Consultants International Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.4.5 D'Antonio Consultants International Recent Development
11.5 Enesi Pharma
11.5.1 Enesi Pharma Company Detail
11.5.2 Enesi Pharma Business Overview
11.5.3 Enesi Pharma Microneedles and Needle-Free Injection Systems Introduction
11.5.4 Enesi Pharma Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.5.5 Enesi Pharma Recent Development
11.6 PharmaJet
11.6.1 PharmaJet Company Detail
11.6.2 PharmaJet Business Overview
11.6.3 PharmaJet Microneedles and Needle-Free Injection Systems Introduction
11.6.4 PharmaJet Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.6.5 PharmaJet Recent Development
11.7 Inolife Sciences
11.7.1 Inolife Sciences Company Detail
11.7.2 Inolife Sciences Business Overview
11.7.3 Inolife Sciences Microneedles and Needle-Free Injection Systems Introduction
11.7.4 Inolife Sciences Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.7.5 Inolife Sciences Recent Development
11.8 Valeritas
11.8.1 Valeritas Company Detail
11.8.2 Valeritas Business Overview
11.8.3 Valeritas Microneedles and Needle-Free Injection Systems Introduction
11.8.4 Valeritas Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.8.5 Valeritas Recent Development
11.9 NanoPass Technologies
11.9.1 NanoPass Technologies Company Detail
11.9.2 NanoPass Technologies Business Overview
11.9.3 NanoPass Technologies Microneedles and Needle-Free Injection Systems Introduction
11.9.4 NanoPass Technologies Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.9.5 NanoPass Technologies Recent Development
11.10 Micropoint Technologies
11.10.1 Micropoint Technologies Company Detail
11.10.2 Micropoint Technologies Business Overview
11.10.3 Micropoint Technologies Microneedles and Needle-Free Injection Systems Introduction
11.10.4 Micropoint Technologies Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.10.5 Micropoint Technologies Recent Development
11.11 Nemaura Pharma
11.11.1 Nemaura Pharma Company Detail
11.11.2 Nemaura Pharma Business Overview
11.11.3 Nemaura Pharma Microneedles and Needle-Free Injection Systems Introduction
11.11.4 Nemaura Pharma Revenue in Microneedles and Needle-Free Injection Systems Business (2018-2023)
11.11.5 Nemaura Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Inovio Pharmaceuticals
3M
Medical International Technology
D'Antonio Consultants International
Enesi Pharma
PharmaJet
Inolife Sciences
Valeritas
NanoPass Technologies
Micropoint Technologies
Nemaura Pharma
听
听
*If Applicable.
